Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
about
Differences of basic and induced autophagic activity between K562 and K562/ADM cells.Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia.The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought
P2860
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
@en
type
label
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
@en
prefLabel
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
@en
P2093
P2860
P356
P1476
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
@en
P2093
Albertus T J Wierenga
André B Mulder
Edo Vellenga
Hendrik Folkerts
Jennifer Jaques
Paul J Coffer
Susan Hilgendorf
P2860
P356
10.1038/CDDIS.2017.317
P577
2017-07-13T00:00:00Z